Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases

• by S R Murthy Madiraju, Elite Possik, Fahd Al-Mulla, Christopher J Nolan, Marc Prentki

• September 10, 2025

Gilead and Merck’s latest trial success and flop

• by Elaine Chen

• June 9, 2026

Cardiac and aerobic response to growth hormone therapy in children with short stature: a prospective study using VO2max and speckle tracking echocardiography

• by Ignacio Ruiz del Olmo-Izuzquiza, Antonio de Arriba-Muñoz, Lorenzo Jiménez-Montañés, Ángel Matute-Llorente, Marta Vara-Callau, Marta Ferrer-Lozano, José-Antonio Casajús-Mallén, José-Ignacio Labarta-Aizpún

• May 28, 2026

SGLT2 Inhibitors Tied to Lower Kidney Cancer Risk

A Korean cohort study found fewer kidney cancer cases among patients with type 2 diabetes who initiated sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors.

• by Andrea Surnit

• June 9, 2026

• 5 min